Home › Funds › TPG GP A, LLC › ACHV

TPG GP A, LLC position in ACHV

ACHIEVE LIFE SCIENCE INC · Health Care

TPG GP A, LLC reported holding 6,877,580 shares of ACHV (ACHIEVE LIFE SCIENCE INC) in its Q2 2026 13F filing — a position valued at US$44.9M, representing 0.92% of its reported portfolio and ranking #14 among its reported holdings. TPG GP A, LLC first reported this position in Q2 2026.

Latest position (Q2 2026)6.88M sh
Reported value held$44.91M
Portfolio Weight0.92%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TPG GP A, LLC's ACHV position evolved

TPG GP A, LLC first disclosed a stake in ACHV in Q2 2026 at 6,877,580 shares (US$44.9M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 6.88M $44.91M New

About ACHV and 13F data

ACHV (ACHIEVE LIFE SCIENCE INC) is a Health Care company. 63 other funds we track also report a position in ACHV — the largest reported positions include Frazier Life Sciences Management, L.P. (US$49.7M), venBio Partners LLC (US$38.6M), Logos Global Management LP (US$35.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACHV

All ACHV fund holders →

FAQ

How long has TPG GP A, LLC held ACHV?

TPG GP A, LLC has disclosed ACHV holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is TPG GP A, LLC's current position in ACHV?

As of Q2 2026, TPG GP A, LLC holds 6.88M shares of ACHV (ACHIEVE LIFE SCIENCE INC), valued at $44.91M, representing 0.92% of its reported portfolio and ranking #14.

Has TPG GP A, LLC been buying or selling ACHV?

In the latest 13F filing (Q2 2026), TPG GP A, LLC newly opened its position in ACHV.

Which other funds hold ACHV?

Other major institutional holders of ACHV include Frazier Life Sciences Management, L.P., venBio Partners LLC, Logos Global Management LP, among 63 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.